Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with...
Transcript of Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with...
![Page 1: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/1.jpg)
LOBULAR NEOPLASIA
Jean F. Simpson, M.D.
Breast Pathology Consultants, Inc.
Nashville, TN
![Page 2: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/2.jpg)
Lobular Neoplasia
• Atypical lobular hyperplasia
• Lobular carcinoma in situ
![Page 3: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/3.jpg)
Relative Risk for Developing
Cancer After Benign Biopsy
• No increased risk
– cysts
– duct ectasia
– adenosis
– hyperplasia, mild
• Slightly increased
risk
– hyperplasia, moderate
or florid, no atypia
– sclerosing adenosis
– solitary papilloma
• Moderately increased risk
– Atypical ductal hyperplasia
– Atypical lobular hyperplasia
![Page 4: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/4.jpg)
LCIS NormalALH
Lobular Neoplasia
![Page 5: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/5.jpg)
![Page 6: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/6.jpg)
![Page 7: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/7.jpg)
![Page 8: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/8.jpg)
![Page 9: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/9.jpg)
![Page 10: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/10.jpg)
![Page 11: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/11.jpg)
![Page 12: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/12.jpg)
Epidemiology of LCIS
Study- Dx term # pts* Incidence
(%)
Relative
risk
%IBC/yrs
follow-up
Rosen (1978) LCIS 99 1.3 9.0 1.52
Page (1991) LCIS 44 0.5 9.0 1.27
Wheeler (1974) LCIS 32 0.8 -- 0.7
Andersen (1974 ) LCIS 47 1.5 12.0 1.4
Haagensen (1978) LN 211 3.8 7.2 1.21
Page (1985) ALH 126 1.6 4.2 0.75
*average age for all series 45 years old
![Page 13: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/13.jpg)
Epidemiology of LCIS
Study- Dx term # pts* incidence Relative
risk
%IBC/yrs
follow-up
Rosen (1978) LCIS 99 1.3 9.0 1.52
Page (1991) LCIS 44 0.5 9.0 1.27
Wheeler (1974) LCIS 32 0.8 -- 0.7
Andersen (1974 ) LCIS 47 1.5 12.0 1.4
Haagensen (1978) LN 211 3.8 7.2 1.21
Page (1985) ALH 126 1.6 4.2 0.75
*average age for all series 45 years old
![Page 14: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/14.jpg)
Nashville Breast Cohort
Risk of Subsequent Carcinoma after
Diagnosis of Lobular Neoplasia
Minimal ALH
ALH
ALH and DIALH
LCIS
1.2-1.5X
4-5X
7X
10X
1.6 %
0.6 %
0.5 %
% BiopsiesRelative RiskCategory
![Page 15: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/15.jpg)
![Page 16: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/16.jpg)
Risk of subsequent carcinoma after
diagnosis of lobular neoplasia may
vary with menopausal status
Premenopausal 9.6 3.3-27.8
Postmenopausal 3.7 1.3-10.2
95% CIRelative Risk
Marshall et al.
Cancer Epidemiol Biomarkers Prev 1997; 6:297-301
![Page 17: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/17.jpg)
Page et. al. Lancet 2003: 361:125-29
“Atypical lobular hyperplasia as a unilateral predictor of
breast cancer risk: a retrospective cohort study”
Biopsy only
20% (50/252) IBC
14.8 yrs Ave F/U
Relative Risk 3.1 (95% CI, 2.3-4.3; P<0.0001)
252 Women with ALH
![Page 18: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/18.jpg)
Laterality of subsequent IMC in relation to
biopsy side for 50 women having ALH
68%
24%
4% 4%
Ipsilateral (34)
Contralateral (12)
Bilateral (2)
Unknown side (2)
Page et. al. Lancet 2003: 361:125-29
![Page 19: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/19.jpg)
Risk of Invasive Breast Cancer Associated with ALH
Prospective Case-Control
1976-1988
10 yrs ave F/U
Relative Risk 5.2 (2.5-10.9)
121, 700 female nurses
Nurses Health Study
Harvard
Nashville Breast Cohort
Vanderbilt
1952-1968
Retrospective
Relative Risk 4.2 (2.6-6.9)
17.5 yrs ave F/U>10,000 biopsies (1.6% ALH)
w/Fam Hx 8.4 (3.5-20)
15 yr
Absolute risk31-45 yrs 8%
46-55 yrs 12%CA: 62% Ipsi, 39% Contra
CA: 69% Ipsi, 31%Contra
![Page 20: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/20.jpg)
Non-Obligate Precursor
Intermediate between
Local Precursor
and
Generalized Risk Factor for
Both Breasts
Page et. al. Lancet 2003: 361:125-29
ALH
![Page 21: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/21.jpg)
Current Considerations
• How do we define lobular
neoplasia?
• Differential diagnosis
• LN on core biopsy
![Page 22: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/22.jpg)
Lobular Neoplasia
1970 2019
detection incidentalcalcification
![Page 23: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/23.jpg)
Incidental ALH
![Page 24: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/24.jpg)
![Page 25: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/25.jpg)
Lobular Neoplasia
1970 2019
detection incidental calcification
diagnosis H & E E-cadherin?
![Page 26: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/26.jpg)
Loss of 16q in both ILC and LN
Ubiquitous loss of 16q includes the locus for
E-cadherin
![Page 27: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/27.jpg)
![Page 28: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/28.jpg)
![Page 29: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/29.jpg)
![Page 30: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/30.jpg)
![Page 31: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/31.jpg)
![Page 32: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/32.jpg)
TERMINOLOGY FOR LN• In the Nashville Cohort and Nurse’s
Health follow up studies, ALH is majority of
cases
• Extensive disease with lobular unit
distortion overlaps with DCIS - as in
NSABP 17, over 100 cases of ‘LCIS’ in
the study of DCIS
![Page 33: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/33.jpg)
![Page 34: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/34.jpg)
![Page 35: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/35.jpg)
![Page 36: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/36.jpg)
![Page 37: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/37.jpg)
![Page 38: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/38.jpg)
![Page 39: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/39.jpg)
CLASSIC LCIS (AND ALH)
• age of diagnosis is 49 years
• incidental histologic finding
• often multifocal and bilateral
• invasive carcinomas can occur in either
breast, and show a variety of histologic
subtypes
![Page 40: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/40.jpg)
CLASSIC LCIS (AND ALH)
• Margins are not assessed
• Classic LCIS and atypical lobular
hyperplasia lack E-cadherin expression,
and show a dyshesive growth pattern
• Classic LCIS and atypical lobular
hyperplasia generally express estrogen
receptor
![Page 41: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/41.jpg)
VARIANT LCIS (PLEOMORPHIC)
• Affects older women, 55-60 years of age
• Presents as an imaging abnormality:
pleomorphic calcifications with or without a
mass.
• Frequently associated with an invasive
component showing similar cytologic
features, strongly supporting its role as a
precursor lesion
![Page 42: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/42.jpg)
VARIANT LCIS (PLEOMORPHIC)
• Lacks E-cadherin expression, and shows
a dyshesive growth pattern
• Surgeons attempt to obtain clear margins
• May be HER2 over-expressed/amplified
• Some cases do not express estrogen
receptor.
• Pleomorphic ALH does not exist.
![Page 43: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/43.jpg)
DCIS AND VARIANT LCIS
• Same age at diagnosis (i.e. 55-60 years)
• Both present as an imaging abnormality:
calcifications or mass
• Excision to negative margins is attempted
for both
• The invasive carcinomas that occur
following DCIS affect the same quadrant,
supporting a precursor role
![Page 44: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/44.jpg)
DCIS AND VARIANT LCIS
• The invasive carcinomas that occur
following pleomorphic LCIS affect the
ipsilateral breast, supporting a precursor
role
• HER2 may be over-expressed/amplified in
both pleomorphic LCIS and DCIS.
![Page 45: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/45.jpg)
Use of IHCReliably separates well-developed examples
of Disease A from Disease B
•Borderline cases, overlaps
•Often unresolvable in simple “yes/no” terms
•Requires integration of therapeutic
modalities in making clinical decisions
![Page 46: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/46.jpg)
Diagnosing LCIS
• Consider clinical context
• Incidental versus targeted lesion
• Current state is different from incidental
findings of pre-mammographic era
![Page 47: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/47.jpg)
Rules for LCIS
Rule #1. Clinical context is everything
Rule #2. Ancillary studies (E-cadherin) may
be helpful
Rule # 3. if E-Cadherin gives mixed
messages, see Rule #1.
![Page 48: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/48.jpg)
Sample Diagnoses
• In situ carcinoma with mixed ductal and lobular featues– Recommend treating as DCIS
• Ductal carcinoma in situ with lobular cytology– Expected biologic behavior that of DCIS
• Pleomorphic lobular carcinoma in situ
• Indeterminate carcinoma in situ
![Page 49: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/49.jpg)
Differential Diagnosis
![Page 50: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/50.jpg)
![Page 51: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/51.jpg)
![Page 52: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/52.jpg)
![Page 53: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/53.jpg)
![Page 54: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/54.jpg)
ALH admixed with florid hyperplasia
![Page 55: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/55.jpg)
ALH involving collagenous spherulosis
![Page 56: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/56.jpg)
![Page 57: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/57.jpg)
![Page 58: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/58.jpg)
![Page 59: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/59.jpg)
![Page 60: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/60.jpg)
Lobular neoplasia
• Incidental finding, multicentric (60%), bilateral (30%)
• No evidence that amount of involvement (within the breast) influences subsequent cancer risk in long term follow up series
• Risk of cancer development is about 10% over 10-15 years, drops after menopause
• Bilateral risk, but ipsilateral breast more likely to develop cancer
• Most women don’t develop cancer
![Page 61: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/61.jpg)
![Page 62: Update on Premalignant Breast Disease - MUSC Path Labdiagnosis of lobular neoplasia may vary with menopausal status Premenopausal 9.6 3.3-27.8 Postmenopausal 3.7 1.3-10.2 Relative](https://reader034.fdocuments.in/reader034/viewer/2022042104/5e81956e5e86131ac0640f68/html5/thumbnails/62.jpg)
Thank You!